Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2007-06-29
2010-10-05
Carr, Deborah D (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S546000
Reexamination Certificate
active
07807718
ABSTRACT:
Provided are alternative sources of ketone bodies for reducing or eliminating symptoms of Parkinson's disease, amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease), Alzheimer's disease, Huntington's disease, epilepsy and other diseases or disorders characterized by impaired glucose metabolism. The alternative sources of ketone bodies include mono-, di- and triglyceride esters of acetoacetate and mixtures thereof, and/or mono-, di- and triglyceride esters of 3-hydroxybutyrate and mixtures thereof. These glyceride esters can be administered orally as a dietary supplement or in a nutritional composition.
REFERENCES:
patent: 5093044 (1992-03-01), Wretlind et al.
patent: 6207856 (2001-03-01), Veech
patent: 6323237 (2001-11-01), Veech
patent: 6380244 (2002-04-01), Martin et al.
patent: 6835750 (2004-12-01), Henderson
patent: 7351736 (2008-04-01), Veech
patent: 2004/0171671 (2004-09-01), Veech
patent: 2006/0115880 (2006-06-01), Ghoul et al.
patent: 2006/0280721 (2006-12-01), Veech et al.
patent: WO 95/09144 (1995-04-01), None
patent: WO 95/09146 (1996-04-01), None
Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study; Neurology, 64:728-730; (1 pg), 2005.
Intravenous Feeding of the Rat with Short Chain Fatty acid Esters, II. Monacetoacetin; (2 pages) , 1978.
Monoglyceryl Acetoacetate: A Ketone Body-carbohydrate Substrate For Parenteral Feeding of the Rat; J. Nult. 109: 1168-1174 (1979) (7 pages).
A Ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis; BMC Neuroscience (2006)7:29 (6 pages).
Galante Jenifer Heydinger
Hashim Sami A.
Jusis Joanna
Rongione Joseph C.
Carr Deborah D
Cowan Liebowitz & Latman P.C.
Hashim Sami A.
Montague, Esq. Mark
LandOfFree
Glyceride esters for the treatment of diseases associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glyceride esters for the treatment of diseases associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glyceride esters for the treatment of diseases associated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4218338